TipRanks
Go Ultimate55% OFF

Dennis Lanfear Insider Profile

4 Followers

Dennis Lanfear, President & CEO, Director at Coherus Biosciences, holds 1.57M shares in Coherus Biosciences (Ticker: CHRS), holds 168.40K shares in Insmed (Ticker: INSM).

Dennis Lanfear's Trading History

CHRS
Coherus Biosciences
Jan 26, 2026President & CEO, DirectorUninformative Buy―$1.30M
INSM
Insmed
Jun 11, 2010DirectorUninformative Buy―$18.96M

You May Also Like

Dennis Lanfear insider profile FAQ

What is the percentage of profitable transactions made by Dennis Lanfear?
The percentage of profitable transactions made by Dennis Lanfear is 80%.
What is the average return per transaction made by Dennis Lanfear?
The average return per transaction made by Dennis Lanfear is 7.50%.
What stocks does Dennis Lanfear hold?
Dennis Lanfear holds: CHRS, INSM stocks.
What was Dennis Lanfear's most profitable transaction?
Dennis Lanfear’s most profitable transaction was an Informative Sell of CHRS stock on June 8, 2021. The return on the trade was 43.00%.
What is Dennis Lanfear's role in Coherus Biosciences?
Dennis Lanfear's role in Coherus Biosciences is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.